Corticosteroid-induced apoptosis in mouse airway epithelium: effect in normal airways and after allergen-induced airway inflammation.

BACKGROUND Damage to the airway epithelium is one prominent feature of the damage seen in chronic asthma. Cortico-steroids induce apoptosis in inflammatory cells, which in part explains their ability to suppress airway inflammation. However, corticosteroid therapy does not necessarily reverse the epithelial damage seen in asthmatic airways. OBJECTIVE We hypothesized that corticosteroids might induce airway epithelial cell apoptosis as one potential explanation for this persistent damage. METHODS BALB/c mice were treated with 1 mg/kg dexamethasone by means of intraperitoneal injection for 3 days to 4 weeks. Additional mice were sensitized and challenged with ovalbumin and then followed for 14 days with or without dexamethasone treatment starting on day 4 after challenge. Apoptosis was measured by using terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling and immunohistochemistry for the p85 cleavage product of poly (adenosine diphosphate-ribose) polymerase. Shed epithelial cells were counted in bronchoalveolar lavage fluid. RESULTS In a time-dependent manner dexamethasone treatment increased epithelial cell apoptosis and shedding into the airway lumen. This was not associated with any change in the abundance of the apoptotic regulator Bcl-x(L). In animals sensitized and challenged with ovalbumin, treatment with 1 mg/kg dexamethasone starting 4 days after challenge reversed the inflammatory changes but did not reverse either epithelial cell shedding or apoptosis seen after allergen challenge. CONCLUSION Corticosteroids might induce apoptotic cell death of airway epithelium in vivo and fail to mitigate epithelial cell shedding and apoptosis elicited by means of allergen challenge. This raises the possibility that at least one of the major components of chronic airway damage in asthma, epithelial shedding, might in part result from a major therapy used for disease control.

[1]  Steven Sun,et al.  Apoptosis of airway epithelial cells induced by corticosteroids. , 2001, American journal of respiratory and critical care medicine.

[2]  J. Bousquet,et al.  Proliferation and activation of bronchial epithelial cells in corticosteroid-dependent asthma. , 2001, The Journal of allergy and clinical immunology.

[3]  P. Gama,et al.  Cell proliferation and death in the gastric epithelium of developing rats after glucocorticoid treatments , 2000, The Anatomical record.

[4]  P. Thompson,et al.  Tight junction properties of the immortalized human bronchial epithelial cell lines Calu-3 and 16HBE14o-. , 2000, The European respiratory journal.

[5]  M. Göke,et al.  Glucocorticoids have pleiotropic effects on small intestinal crypt cells. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[6]  P. Forgez,et al.  In vitro effects of dexamethasone on human corneal keratocytes. , 1999, Investigative ophthalmology & visual science.

[7]  I. Tillie‐Leblond,et al.  Apoptosis, proliferation, and expression of Bcl-2, Fas, and Fas ligand in bronchial biopsies from asthmatics. , 1998, American journal of respiratory cell and molecular biology.

[8]  G. D. De Meyer,et al.  RNA synthesis and splicing interferes with DNA in situ end labeling techniques used to detect apoptosis. , 1998, The American journal of pathology.

[9]  J. Bluestone,et al.  CTLA4Ig inhibits airway eosinophilia and hyperresponsiveness by regulating the development of Th1/Th2 subsets in a murine model of asthma. , 1998, American journal of respiratory cell and molecular biology.

[10]  P. Barnes,et al.  Current issues for establishing inhaled corticosteroids as the antiinflammatory agents of choice in asthma. , 1998, The Journal of allergy and clinical immunology.

[11]  J. Bousquet,et al.  Airway inflammation in mild intermittent and in persistent asthma. , 1998, American journal of respiratory and critical care medicine.

[12]  G. Rosen,et al.  Dexamethasone inhibits lung epithelial cell apoptosis induced by IFN-γ and Fas. , 1997, American journal of physiology. Lung cellular and molecular physiology.

[13]  K. Adler,et al.  Epithelial injury induced by exposure to residual oil fly-ash particles: role of reactive oxygen species? , 1997, American journal of respiratory cell and molecular biology.

[14]  R. Godfrey Human airway epithelial tight junctions , 1997, Microscopy research and technique.

[15]  P. Howarth,et al.  The effect of treatment with oral corticosteroids on asthma symptoms and airway inflammation. , 1997, American journal of respiratory and critical care medicine.

[16]  H. Sasano,et al.  Ultrastructural and confocal laser scanning microscopic examination of TUNEL‐positive cells , 1997, The Journal of pathology.

[17]  P. S. Gilmour,et al.  Free radical activity and pro-inflammatory effects of particulate air pollution (PM10) in vivo and in vitro. , 1996, Thorax.

[18]  A. J. Wilson,et al.  Eosinophil apoptosis and the resolution of airway inflammation in asthma. , 1996, American journal of respiratory and critical care medicine.

[19]  J. M. Cousin,et al.  Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. , 1996, Journal of immunology.

[20]  R. Jaggi,et al.  Glucocorticoid and progesterone inhibit involution and programmed cell death in the mouse mammary gland , 1995, The Journal of cell biology.

[21]  M. O'hare,et al.  The induction of apoptosis in human mammary luminal epithelial cells by expression of activated c-neu and its abrogation by glucocorticoids. , 1995, British Journal of Cancer.

[22]  G. Firestone,et al.  Relationship of serine/threonine phosphorylation/dephosphorylation signaling to glucocorticoid regulation of tight junction permeability and ZO-1 distribution in nontransformed mammary epithelial cells. , 1994, The Journal of biological chemistry.

[23]  P. Barnes,et al.  Efficacy and Safety of Inhaled Corticosteroids in Asthma , 1993 .

[24]  S. Ben‐Sasson,et al.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation , 1992, The Journal of cell biology.

[25]  T. Haahtela,et al.  A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta 2-agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. , 1992, The Journal of allergy and clinical immunology.

[26]  A. Foresi,et al.  Inflammatory markers in bronchoalveolar lavage and in bronchial biopsy in asthma during remission. , 1990, Chest.

[27]  I. Adamson,et al.  Epithelial cell-fibroblast interactions in lung injury and repair. , 1990, The American journal of pathology.

[28]  K. Chung,et al.  The effects of activated eosinophils and neutrophils on guinea pig airway epithelium in vitro. , 1990, American journal of respiratory cell and molecular biology.

[29]  S. Holgate,et al.  Cellular events in the bronchi in mild asthma and after bronchial provocation. , 1989, The American review of respiratory disease.

[30]  T. Haahtela,et al.  Damage of the airway epithelium and bronchial reactivity in patients with asthma. , 1985, The American review of respiratory disease.

[31]  L. Laitinen,et al.  Remodeling of asthmatic airways by glucocorticosteroids. , 1996, The Journal of allergy and clinical immunology.

[32]  J. Cidlowski,et al.  Rapid in vivo effects of glucocorticoids on the integrity of rat lymphocyte genomic deoxyribonucleic acid. , 1986, Endocrinology.

[33]  D. Loegering,et al.  Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium. , 1980, Laboratory investigation; a journal of technical methods and pathology.